PE20211769A1 - Compuestos heteroaromaticos como inhibidores de vanina - Google Patents
Compuestos heteroaromaticos como inhibidores de vaninaInfo
- Publication number
- PE20211769A1 PE20211769A1 PE2021000809A PE2021000809A PE20211769A1 PE 20211769 A1 PE20211769 A1 PE 20211769A1 PE 2021000809 A PE2021000809 A PE 2021000809A PE 2021000809 A PE2021000809 A PE 2021000809A PE 20211769 A1 PE20211769 A1 PE 20211769A1
- Authority
- PE
- Peru
- Prior art keywords
- membered
- vanin
- compounds
- together form
- heterocyclyl containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion se refiere a un compuesto de formula I, o una sal aceptable de este, en donde: n es 1 o 2; R1, R2 y R3 son independientemente alquilo C1-C4 opcionalmente sustituido con hidroxi, CH3-O-, entre otros, o R2 y R3 juntos forman un carbociclo de 3-6 miembros o un heterociclilo de 4-6 miembros que contienen un heteroatomo seleccionado del grupo que consiste en N y O, o R1, R2 y R3 juntos forman un carbociclo biciclico de 5-8 miembros o un heterociclilo biciclico de 6-8 miembros que contiene un heteroatomo seleccionado de N y O; R4 es heteroarilo de 5-6 miembros, heterociclilo de 5-6 miembros, entre otros; R5 es H o alquilo C1-C2, o R4 y R5 juntos forman un heterociclilo de 4-6 miembros que contiene 1 heteroatomo seleccionado de N y O. Son compuestos especificos los compuestos 1.2, 1.3, 1.5, entre otros. Tambien se refiere a una composicion farmaceutica. Dichos compuestos son potentes inhibidores de la enzima Vanina 1, siendo utiles en el tratamiento de enfermedades relacionadas con Vanina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18209721 | 2018-12-03 | ||
| PCT/EP2019/083252 WO2020114943A1 (en) | 2018-12-03 | 2019-12-02 | Heteroaromatic compounds as vanin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20211769A1 true PE20211769A1 (es) | 2021-09-07 |
Family
ID=64572152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2021000809A PE20211769A1 (es) | 2018-12-03 | 2019-12-02 | Compuestos heteroaromaticos como inhibidores de vanina |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US11078182B2 (es) |
| EP (1) | EP3891139A1 (es) |
| JP (2) | JP7130873B2 (es) |
| KR (1) | KR20210100150A (es) |
| CN (2) | CN114478485B (es) |
| AR (1) | AR117229A1 (es) |
| AU (1) | AU2019391279B2 (es) |
| BR (1) | BR112021007915A2 (es) |
| CA (1) | CA3116830A1 (es) |
| CL (2) | CL2021001198A1 (es) |
| CO (1) | CO2021007173A2 (es) |
| CR (1) | CR20210294A (es) |
| DO (1) | DOP2021000071A (es) |
| EA (1) | EA202191476A1 (es) |
| EC (1) | ECSP21040278A (es) |
| IL (1) | IL283397B2 (es) |
| JO (2) | JOP20210127A1 (es) |
| MA (1) | MA54378A (es) |
| MX (1) | MX2021006520A (es) |
| PE (1) | PE20211769A1 (es) |
| PH (1) | PH12021551280A1 (es) |
| SA (1) | SA521422152B1 (es) |
| SG (1) | SG11202104437XA (es) |
| TW (1) | TWI838430B (es) |
| UA (1) | UA128374C2 (es) |
| WO (1) | WO2020114943A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE061186T2 (hu) | 2018-08-28 | 2023-06-28 | Boehringer Ingelheim Int | Heteroaromás vegyületek mint vanin-inhibitorok |
| MX2021006265A (es) | 2018-11-30 | 2021-10-01 | Comet Therapeutics Inc | Derivados de panteteina y usos de los mismos. |
| CA3116830A1 (en) * | 2018-12-03 | 2020-06-11 | Boehringer Ingelheim International Gmbh | Heteroaromatic compounds as vanin inhibitors |
| CA3120037A1 (en) | 2018-12-03 | 2020-06-11 | Boehringer Ingelheim International Gmbh | Heteroaromatic compounds as vanin inhibitors |
| BR112021010690A2 (pt) | 2018-12-03 | 2021-08-24 | Boehringer Ingelheim International Gmbh | Compostos heteroaromáticos como inibidores de vanina |
| WO2021174024A1 (en) | 2020-02-28 | 2021-09-02 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
| KR20240158968A (ko) * | 2022-03-18 | 2024-11-05 | 상하이 메이유에 바이오테크 디벨롭먼트 컴퍼니 리미티드 | Vanin 효소 억제제의 염 형태, 결정형 및 이의 제조 방법과 용도 |
| AU2024241337A1 (en) * | 2023-03-21 | 2025-10-02 | Athos Therapeutics, Inc. | Vanin-1 inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030195192A1 (en) * | 2002-04-05 | 2003-10-16 | Fortuna Haviv | Nicotinamides having antiangiogenic activity |
| DE602004018811D1 (de) | 2003-10-09 | 2009-02-12 | Abbott Lab | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |
| AU2013324696B2 (en) | 2012-09-25 | 2017-09-14 | Merck Patent Gmbh | Alpha hydroxy amides |
| EP3303303A1 (en) | 2015-05-29 | 2018-04-11 | Pfizer Inc | Novel heterocyclic compounds as inhibitors of vanin-1 enzyme |
| SG11201811161YA (en) * | 2016-07-14 | 2019-01-30 | Pfizer | Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme |
| PL3638680T3 (pl) | 2017-06-12 | 2022-12-19 | Boehringer Ingelheim International Gmbh | Związki heteroaromatyczne jako inhibitory waniny |
| HUE061186T2 (hu) | 2018-08-28 | 2023-06-28 | Boehringer Ingelheim Int | Heteroaromás vegyületek mint vanin-inhibitorok |
| CA3116830A1 (en) * | 2018-12-03 | 2020-06-11 | Boehringer Ingelheim International Gmbh | Heteroaromatic compounds as vanin inhibitors |
| CA3120037A1 (en) * | 2018-12-03 | 2020-06-11 | Boehringer Ingelheim International Gmbh | Heteroaromatic compounds as vanin inhibitors |
| BR112021010690A2 (pt) * | 2018-12-03 | 2021-08-24 | Boehringer Ingelheim International Gmbh | Compostos heteroaromáticos como inibidores de vanina |
-
2019
- 2019-12-02 CA CA3116830A patent/CA3116830A1/en active Pending
- 2019-12-02 AU AU2019391279A patent/AU2019391279B2/en active Active
- 2019-12-02 CN CN202210061725.6A patent/CN114478485B/zh active Active
- 2019-12-02 CN CN201980078414.7A patent/CN113166104A/zh active Pending
- 2019-12-02 WO PCT/EP2019/083252 patent/WO2020114943A1/en not_active Ceased
- 2019-12-02 PE PE2021000809A patent/PE20211769A1/es unknown
- 2019-12-02 TW TW108143868A patent/TWI838430B/zh active
- 2019-12-02 MA MA054378A patent/MA54378A/fr unknown
- 2019-12-02 JO JOP/2021/0127A patent/JOP20210127A1/ar unknown
- 2019-12-02 SG SG11202104437XA patent/SG11202104437XA/en unknown
- 2019-12-02 JP JP2021531556A patent/JP7130873B2/ja active Active
- 2019-12-02 IL IL283397A patent/IL283397B2/en unknown
- 2019-12-02 MX MX2021006520A patent/MX2021006520A/es unknown
- 2019-12-02 EP EP19817182.9A patent/EP3891139A1/en active Pending
- 2019-12-02 JO JOP/2021/0128A patent/JOP20210128A1/ar unknown
- 2019-12-02 AR ARP190103518A patent/AR117229A1/es not_active Application Discontinuation
- 2019-12-02 US US16/699,799 patent/US11078182B2/en active Active
- 2019-12-02 EA EA202191476A patent/EA202191476A1/ru unknown
- 2019-12-02 KR KR1020217020910A patent/KR20210100150A/ko active Pending
- 2019-12-02 BR BR112021007915-7A patent/BR112021007915A2/pt unknown
- 2019-12-02 UA UAA202103638A patent/UA128374C2/uk unknown
- 2019-12-02 CR CR20210294A patent/CR20210294A/es unknown
-
2021
- 2021-04-16 DO DO2021000071A patent/DOP2021000071A/es unknown
- 2021-05-06 CL CL2021001198A patent/CL2021001198A1/es unknown
- 2021-05-31 CO CONC2021/0007173A patent/CO2021007173A2/es unknown
- 2021-06-01 SA SA521422152A patent/SA521422152B1/ar unknown
- 2021-06-01 PH PH12021551280A patent/PH12021551280A1/en unknown
- 2021-06-03 EC ECSENADI202140278A patent/ECSP21040278A/es unknown
- 2021-06-25 US US17/358,111 patent/US20220048885A1/en not_active Abandoned
- 2021-12-30 CL CL2021003568A patent/CL2021003568A1/es unknown
-
2022
- 2022-08-24 JP JP2022133354A patent/JP2022188014A/ja not_active Withdrawn
- 2022-11-02 US US18/051,953 patent/US20230295112A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20211769A1 (es) | Compuestos heteroaromaticos como inhibidores de vanina | |
| PE20230249A1 (es) | Compuestos de heteroarilo biciclicos y usos de estos | |
| AR114164A1 (es) | Piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1 | |
| CL2022001392A1 (es) | Compuestos tricíclicos sustituidos | |
| PE20191817A1 (es) | Tienopiridinas y benzotiofenos utiles como inhibidores de cinasa 4 asociada al receptor de interleucina 1 (irak4) | |
| PE20220931A1 (es) | Inhibidores de shp2 fosfatasa de tipo pirazolo[3,4-b]pirazina | |
| CU20190086A7 (es) | Compuestos de heteroarilo bicíclicos 6-6 fusionados útiles como inhibidores de lats | |
| PE20190326A1 (es) | Isoquinolin-3-il-carboxamidas y preparacion y uso de las mismas | |
| AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
| PE20190705A1 (es) | COMPUESTOS DE BENZO[b] TIOFENO COMO AGONISTAS DE STING | |
| PE20152033A1 (es) | Heterociclos bicicliclos como inhibidores de fgfr | |
| PE20190656A1 (es) | Compuestos de tiazolo-piridina sustituida como inhibidores de malt1 | |
| PE20181298A1 (es) | Inhibidores de bromodominio bivalentes y usos de los mismos | |
| PE20191613A1 (es) | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret | |
| PE20220567A1 (es) | Nuevos derivados piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| PE20151448A1 (es) | Compuestos de tiazolcarboxamidas y piridinacarboxamida utiles como inhibidores de quinasa pim | |
| CL2015002520A1 (es) | Compuestos novedosos de pirimidina y piridina y su uso. | |
| AR088449A1 (es) | Benzilindazoles sustituidos | |
| AR094876A1 (es) | Derivados de ácido betulínico modificados con alquilo c-3 y alquenilo | |
| MX2012002973A (es) | Derivados de pirimidona herbicidas. | |
| PE20190968A1 (es) | Compuestos de heterociclo tetraciclicos utiles como inhibidores de la integrasa del vih | |
| AR111494A1 (es) | Compuestos de anilinoquinazolina c₅ y su uso en el tratamiento del cáncer | |
| BR112016019462B8 (pt) | Compostos heterocïclicos tricïclicos como inibidores de fosfoinosotida 3-cinase | |
| EA201690072A1 (ru) | Состав, содержащий гиполипидемическое средство | |
| PE20150774A1 (es) | Aminoquinolinas como inhibidores de cinasa |